Načítá se...
The impact of cell-of-origin, MYC/Bcl-2 Dual Expression and MYC Rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy
We addressed the prognostic impact of cell-of-origin (COO), MYC and Bcl-2 overexpression as well as isolated MYC rearrangement among 111 patients with limited stage diffuse large B-cell lymphoma (DLBCL) treated with consolidative radiation therapy (RT) after a metabolic complete response to immunoch...
Uloženo v:
| Vydáno v: | Leuk Lymphoma |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8262455/ https://ncbi.nlm.nih.gov/pubmed/33480830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2020.1869965 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|